Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 19, 2025Cancer Epidemiology Biomarkers & Prevention

Abstract B126: Cardiovascular disease mortality among multiple myeloma patients treated with chemoimmunotherapy, 2000-2021

View Full Paper
Ask AI
Bookmark
Share

Authors

JVJacqueline B. VoMLMartha S. LinetKSKeli’i Shontell

Discussion

Loading...

Member takes

Overview

Analysis reveals higher CVD mortality in Black and NHPI patients with multiple myeloma, indicating substantial disparities.

Key Points

  • CVD mortality rates were significantly higher among Black (HR=1.48) and NHPI (HR=2.00) patients compared to White patients.
  • Cumulative CVD mortality was notably affected by age, with younger Black patients showing an HR of 2.54 for those aged 20-49 years.
  • Assessment utilized Cox proportional hazards models to analyze data from 53,910 MM patients treated between 2000 and 2021.
  • Future research should address comorbidities and strategies to reduce CVD mortality disparities among MM patients.

Cite This Study

Vo et al. (2025) studied this question.

synapsesocial.com/papers/68d436f6713b0b5dfea765f2https://doi.org/10.1158/1538-7755.disp25-b126
View Full Paper
Ask AI
Bookmark
Share